RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Prefusion Health Longevity Clinic & Health Optimization NYC Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law